IASIS PHARMA participated in the 1st International Congress of Dermatology & Venereology held on November 01-05, 2023, at the “Du Lac” hotel in Ioannina. The conference was organized by the Hellenic Dermatology & Venereology Society together with the Dermatology & Venereology Society of Cyprus.
At IASIS PHARMA exhibition stand, the unique Isotroin 30mg was presented. Isotroin 30mg completes the range of the other Isotroin contents (10mg, 20mg & 40mg).
- Isotroin®/Isotretinoin is indicated for the severe forms of Acne that are resistant to treatment with systemic antibiotics and topical therapy.
The following products were also presented:
- Modiwart®/Ιmiquimod, an innovative modifier of the immune response system indicated for the treatment of: Condylomata acuminata, small Superficial Basal Cell Carcinomas and Aktinic keratoses.
- Combi®, a combination of fluprednidene+miconazole cream for the treatment of Inflammatory Dermatomycoses such as Vulvovaginal Candidiasis.